Association between patient-to-nurse ratios in emergency departments and patient, staff, and organizational outcomes: a systematic review
Abstract
Background In many settings, studies have shown that establishing patient-to-nurse ratios has benefits for both patients and staff. Whether this is transposable to emergency department (ED) is unclear. Objective The primary objective was to assess the association between patient-to-nurse ratios in EDs and mortality. Design In this systematic review, a search strategy identified studies published in 2004-2025 in MEDLINE, Cochrane, and CINAHL. Two independent reviewers performed selection and data extraction, followed by a narrative synthesis. Outcomes The primary outcome was in-hospital mortality. Secondary outcomes were other patient outcomes, staff, and organizational outcomes. Results Of 2214 identified references, 17 studies were included and all of which were observational. The primary outcome was assessed in only one cohort study ( n = 73 EDs), where an increase in the number of nurses per patient was associated with a reduction in ED mortality (adjusted odds ratio = 0.68; 95% confidence interval: 0.49; 0.94). An increase in the number of nurses per patient was also associated with a reduction in cardiac arrests (one study: relative risk = 1.33, 95% confidence interval: 1.05, 1.67 for ≥8.5 patients/nurse vs. <8.5) and medication errors (one of two studies), and an improvement in patient experience (two studies) and nurse satisfaction (one study). Mixed results were observed with regard to reducing length of stay (one of two studies), administration time (three of four…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 73 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.